Flowers Foods (FLO) just posted fourth quarter FY 2025 revenue of US$1.2b with a basic EPS loss of US$0.32, while trailing twelve month EPS came in at US$0.40 on revenue of US$5.3b. The company has seen quarterly revenue move from US$1.1b and EPS of US$0.20 in Q4 2024 to US$1.2b and EPS of US$0.19 in Q3 2025 before the latest quarterly loss, setting up a results season where investors are weighing weak reported profitability against forecasts for stronger earnings ahead. With net profit margins compressed and trailing results hit by a large one off loss, the latest numbers put the focus squarely on how much of the earnings story is cyclical versus structural.

See our full analysis for Flowers Foods.

With the headline figures on the table, the next step is to see how this earnings print lines up against the widely followed narratives around Flowers Foods' growth, risks, and margin trajectory, and where those stories might need a rethink.

Loss-making quarter pulls trailing margin down to 1.6%

• Across the last twelve months, Flowers Foods earned US$83.8 million of net income on US$5.3b of revenue, which works out to a 1.6% net margin compared with 4.8% a year earlier, with the period also including a one off loss of US$149.5 million.
• Consensus narrative flags pressure on traditional bread and retailer pricing power, and the margin data lines up with that concern:
  • Net income over the last twelve months of US$83.8 million is well below the US$248.1 million level from a year earlier, which fits the idea that category headwinds and higher costs are weighing on profitability.
  • At the same time, FY 2025 revenue of about US$5.3b is broadly similar to the prior year’s US$5.1b. A relatively steady top line together with lower margins is exactly the pattern you would expect if competition and mix are squeezing earnings rather than volume falling sharply.

Flat revenue versus 36.9% earnings growth forecasts

• Revenue is forecast to grow by about 0.07% per year, while earnings are forecast to grow around 36.9% per year, a wide gap given that trailing revenue over the last twelve months has sat in the US$5.1b to US$5.3b range.
• Bulls point to premium and health oriented products as the bridge between flat sales and stronger earnings, and the current numbers partly test that idea:
  • Forecasts assume earnings growth outpacing the broader US market while revenue barely grows. A key bullish claim is that margin improvement and mix shift toward premium lines can do most of the work even if overall sales stay roughly around US$5.3b.
  • The recent drop in trailing EPS from 1.18 twelve months ago to 0.40 now, alongside the one off US$149.5 million loss, means any bullish case is leaning heavily on those forecast margin gains rather than on recent EPS trends, which have softened over the last year.

Bulls argue that earnings can rebound on premium brands even if sales stay flat, while today’s compressed margins show how much needs to change for that to play out. 🐂 Flowers Foods Bull Case

P/E of 26.1x with a DCF fair value of US$23.03

• With a current share price of US$10.36, the stock is trading at a P/E of 26.1x and about 55% below a DCF fair value of US$23.03, while the trailing twelve month EPS of US$0.40 has declined from US$1.18 five years ago, an annual rate of about 4.3%.
• Bears argue that slower category growth, margin pressure, high debt, and a 9.56% dividend that is not well covered by earnings make this apparent valuation gap less straightforward:
  • The current 26.1x P/E is slightly above the US Food industry average of 24.1x despite weaker trailing margin performance. This fits the cautious view that investors are already paying up for earnings that include a meaningful one off hit.
  • When you layer in elevated leverage and a dividend that is not covered by current earnings, the cautious narrative focuses on whether future cash flows will comfortably support both debt and payouts, especially given the drop in trailing net margin from 4.8% to 1.6%.

Skeptics point out that a 26.1x P/E and stretched dividend coverage leave less room for error if earnings do not recover as expected. 🐻 Flowers Foods Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Flowers Foods on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

See the numbers differently? If this update has you thinking in a new direction, you can shape that view into your own narrative in just a few minutes: Do it your way

A great starting point for your Flowers Foods research is our analysis highlighting 2 key rewards and 5 important warning signs that could impact your investment decision.

See What Else Is Out There

With compressed 1.6% net margins, a recent quarterly loss, a 26.1x P/E and a dividend not covered by earnings, the risk profile here is elevated.

If that mix of thin margins and stretched dividend cover has you on edge, check out 85 resilient stocks with low risk scores that prioritise steadier balance sheets and lower overall risk right now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.